WO1999027885A1 - Multiple compartment container for medical solution - Google Patents

Multiple compartment container for medical solution Download PDF

Info

Publication number
WO1999027885A1
WO1999027885A1 PCT/SE1998/002146 SE9802146W WO9927885A1 WO 1999027885 A1 WO1999027885 A1 WO 1999027885A1 SE 9802146 W SE9802146 W SE 9802146W WO 9927885 A1 WO9927885 A1 WO 9927885A1
Authority
WO
WIPO (PCT)
Prior art keywords
glucose
concentration
calcium
contents
compartment
Prior art date
Application number
PCT/SE1998/002146
Other languages
French (fr)
Inventor
Anders Wieslander
Bengt Rippe
Original Assignee
Gambro Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gambro Ab filed Critical Gambro Ab
Priority to JP2000522874A priority Critical patent/JP2001524353A/en
Priority to BR9815055-3A priority patent/BR9815055A/en
Priority to EP98959333A priority patent/EP1035823A1/en
Priority to AU15153/99A priority patent/AU742793B2/en
Priority to KR1020007005381A priority patent/KR20010032191A/en
Priority to CA002311903A priority patent/CA2311903A1/en
Publication of WO1999027885A1 publication Critical patent/WO1999027885A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2093—Containers having several compartments for products to be mixed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/16—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis with membranes
    • A61M1/1654—Dialysates therefor
    • A61M1/1656—Apparatus for preparing dialysates
    • A61M1/1668—Details of containers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/28—Peritoneal dialysis ; Other peritoneal treatment, e.g. oxygenation
    • A61M1/287—Dialysates therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/05—Containers specially adapted for medical or pharmaceutical purposes for collecting, storing or administering blood, plasma or medical fluids ; Infusion or perfusion containers
    • A61J1/10—Bag-type containers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
    • A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
    • A61J1/14—Details; Accessories therefor
    • A61J1/20—Arrangements for transferring or mixing fluids, e.g. from vial to syringe
    • A61J1/2003—Accessories used in combination with means for transfer or mixing of fluids, e.g. for activating fluid flow, separating fluids, filtering fluid or venting
    • A61J1/202—Separating means
    • A61J1/2027—Separating means having frangible parts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/28—Peritoneal dialysis ; Other peritoneal treatment, e.g. oxygenation

Definitions

  • the present invention relates to peritoneal dialysis, where a dialysis solution is present in a multiple compartment container provided with three or more compartments.
  • the invention relates particularly to such a container in which the dialysis solution contains bicarbonate as buffer, as well as glucose and calcium ions.
  • a container for peritoneal dialysis is disclosed in WO 97/05852.
  • the container contains conventional dialysis solution with lactate as buffer.
  • the container thus comprises a first large compartment containing sodium lactate, sodium chloride, calcium chloride and magnesium chloride, as well as two small compartments containing glucose of high concentration and low pH.
  • the container is sterilized in an autoclave with the solutions in situ in said compartments.
  • either one or both of the compartments are connected to the large compartment by frangible pins whereby the dialysis solution contains a desired concentration of glucose, such as 1.5%, 2.5% or 4%.
  • Using a three compartment container it is possible to employ a single container for all three degrees of concentration, which reduces costs for logistics and storage.
  • An object to the present invention is to adapt the container according to WO 97/05852 for such type of peritoneal dialysis in which the lactate buffer is entirely or partially exchanged for a buffer consisting of bicarbonate.
  • bicarbonate cannot, however, be combined with calcium or magnesium in the large compartment since this may lead to precipitation of, for example, carbonates during long term storage or at high pH. Accordingly, bicarbonate and calcium/magnesium must be separated until shortly before use.
  • Glucose and calcium/magnesium are largely compatible, i.e. they do not precipitate.
  • the divalent ions catalyse glucose decomposition to a certain extent .
  • a conventional peritoneal dialysis solution has a calcium ion concentration of 1.75 mM (mmol/1) and a magnesium ion concentration between 0.25-0.50 mM.
  • the buffer may be solely bicarbonate which thereby normally exists at a concentration of 30-40 mM or a combination of bicarbonate and lactate, for example 25 mM bicarbonate and 15 mM lactate.
  • a further object of the present invention is to propose a three compartment container of the above-mentioned type in which the above-mentioned problem is solved.
  • hypocalciemia results in i.a. the following symptoms: cramps, hyper-reflexes, spasms, ECG- changes and hyperparatyroidism.
  • hypocalciemia is normally counteracted by increased intake of calcium carbonate, while the calcium concentration in the dialysis solution is normally kept constant .
  • a peritoneal dialysis solution is to be neutral (in- and outflow the same) with regard to the calcium transport during a four hour period, it should comprise about 1.2 mM calcium at 1.5% glucose, about 1.6 mM at 2.5% glucose and, finally, about 2.3 mM calcium at 4.0% glucose, i.e. the calcium concentration should be substantially proportional to the glucose concentration in the final solution.
  • the final glucose concentration in the mixed solution is determined by the volume of the small compartments since the glucose concentration is identical in the small glucose compartments, for example 50%. This results in that the calcium concentration will always remain proportional to the glucose concentration. The higher the glucose concentration (greater volume) , the more ultrafiltration and thus also higher calcium concentration in the mixed solution.
  • the calcium concentration may in that respect be selected so that the patient either has a net loss, net gain or neutral calcium balance irrespective of the ultra- filtration and the glucose concentration.
  • a further object in the present invention is to provide a three compartment container of the above-mentioned type with bicarbonate in the large compartment and glucose together with calcium in the two small compartments, whereby the increase in the calcium concentration at the highest glucose concentration results in better calcium control than previously.
  • This invention is completely different from previously known methods in which the same calcium concentration has always been used irrespective of the glucose concentration.
  • the large compartment comprises bicarbonate ions and the small compartments comprises glucose and calcium ions .
  • the glucose concentration is substantially proportional to the calcium ion concentration in the finally prepared medical solution.
  • the two small compartments may comprises solutions having the same concentration of glucose and calcium, though having different volumes, or the first of the small compartments contains glucose and calcium ions with such a concentration that the glucose concentration when mixing the contents of said first small compartment with the contents of the large comparment obtains a first predetermined value, such as 1.5%, and the calcium ion concentration obtains a second predetermined value, such as 1.0 mM, while the second of the small compartments contains glucose and calcium ions having such a concentration so that the glucose concentration in the finally prepared solution when mixing the contents of said second small compartment with the contents of the large comparment obtains a third predetermined value, such as 2.5%, and the calcium ion concentration obtains a fourth predetermined value, such as 1.6 mM, and finally the contents of the first and the second of the small compartments may be mixed with the contents of the large compartment to obtain a finally prepared solution with higher concentrations of glucose and calcium ions, such as 4% glucose concentration and 2.5 mM calcium.
  • a first predetermined value such as 1.5%
  • the small compartments may further comprise magnesium ions, for example in a concentration such that the resulting concentration in the finally prepared medical solution is about 0.25-0.75 mM.
  • the invention also relates to a method for preparing a medical solution, particularly for peritoneal dialysis, in a container consisting of a first large compartment having a volume which is sufficiently large to contain the finally prepared medical solution, and a plurality of small compartments which contain partial quantities of the medical solution which are not compatible for long term storage with the contents of the large compartment.
  • the large compartment comprises bicarbonate ions and the small compartments comprise glucose and calcium ions.
  • the contents of one or more of the small compartments are mixed with the contents of the large compartment to produce a medical solution in which the concentration of glucose is substantially proportional to the concentration of calcium ions.
  • the invention also relates to a use of a container for preparation of a peritoneal dialysis solution in which the concentrations of glucose and calcium ions are substantially proportional.
  • Fig. 1 is a plan view of a container which may be used in the present invention.
  • Figs. 2, 3 and 4 are computer-simulated diagrams which show the calcium balance across the peritoneal membrane.
  • Fig. 1 discloses a three compartment container which may be used in the present invention.
  • the container 1 is of the type which is sealed at both ends with weld seams 20 and 21.
  • the container is divided into a large compartment 10 and two small compartments 14 and 15 by weld seams 11, 12 and 13.
  • the small compartment 14 and/or 15 may communicate with the large compartment 10 by means of frangible pins 18, 19 which are normally sealed but can be manually opened. When the frangible pin 18 and/or 19 is opened, the contents in the compartments 14 and/or 15 flow down into the large compartment
  • suitable solution is supplied to the various compartments 10, 14 and 15 via inlet tubes 16, 17 and 22 extending through the weld seams 20 and 21.
  • a sample and/or infusion port 23 extending through the weld seam 21 permits sampling from, and infusion to, the compartment 10.
  • the solution in the compartment 10 is supplied to a patient via a conduit 24.
  • the container is placed on a stand by means of an opening 25 in the upper weld seam 20.
  • the bag described so far is substantially identical to the one disclosed in WO 97/05852.
  • the container preferably has a size such that two litres of peritoneal dialysis solution are accommodated in the large compartment 10 in a ready-mixed state. Larger or smaller containers are of course feasible according to the invention.
  • the container 1 is to be used to prepare a peritoneal dialysis solution in which the buffer consists of bicarbonate. Accordingly, the solutions in the various compartments may be the following.
  • EXAMPLE 1 The compartment 10 contains 1900 ml with the composition:
  • Compartment 14 contains 100 ml of the composition:
  • Compartment 15 contains 100 ml of the composition:
  • a peritoneal dialysis solution is obtained with the following composition:
  • a dialysis solution having the following composition:
  • each of the small compartments has the same composition according to the following:
  • Compartment 10 contains 1950 ml of the composition:
  • Compartment 14 contains 60 ml of the composition:
  • solutions are employed with the following compositions in the various compartments 10, 14 and 15.
  • Compartment 10 contains 1850 ml of the composition:
  • Compartment 14 contains 150 ml of the composition:
  • Compartment 15 contains 260 ml of the composition:
  • the calcium concentration will be somewhat lower than in the first two examples .
  • the pH- value in the small compartments is normally low, about 3.0, in order to prevent glucose decomposition during autoclaving.

Abstract

Container for medical solution, particularly for peritoneal dialysis. A large compartment (10) contains the majority of the medical solution, such as sodium bicarbonate, sodium lactate and sodium chloride. In addition, a plurality of small compartments (14, 15) are provided which contain partial quantities of the medical solution which are not compatible for long term storage with the contents of the large compartment, such as calcium ions and glucose. By mixing the contents of the first (14) or second (15) of the small compartments with the contents of the large compartment (10), a solution is obtained having 1.5 % or 2.5 % glucose and 1.0 mM or 1.6 mM calcium. By mixing the contents of both the small compartments with the contents of the large compartment, a solution is obtained having 4.0 % glucose and 2.5 mM calcium. Due to the increased ultrafiltration at high glucose concentration, these medical solutions are calcium-neutral during use as peritoneal dialysis solutions.

Description

TITLE
Multiple compartment container for medical solution
AREA OF INVENTION
The present invention relates to peritoneal dialysis, where a dialysis solution is present in a multiple compartment container provided with three or more compartments.
The invention relates particularly to such a container in which the dialysis solution contains bicarbonate as buffer, as well as glucose and calcium ions.
PRIOR ART
A container for peritoneal dialysis is disclosed in WO 97/05852. The container contains conventional dialysis solution with lactate as buffer. The container thus comprises a first large compartment containing sodium lactate, sodium chloride, calcium chloride and magnesium chloride, as well as two small compartments containing glucose of high concentration and low pH. The container is sterilized in an autoclave with the solutions in situ in said compartments. During use, either one or both of the compartments are connected to the large compartment by frangible pins whereby the dialysis solution contains a desired concentration of glucose, such as 1.5%, 2.5% or 4%. Using a three compartment container, it is possible to employ a single container for all three degrees of concentration, which reduces costs for logistics and storage.
SUMMARY OF THE INVENTION
An object to the present invention is to adapt the container according to WO 97/05852 for such type of peritoneal dialysis in which the lactate buffer is entirely or partially exchanged for a buffer consisting of bicarbonate.
As is known, bicarbonate cannot, however, be combined with calcium or magnesium in the large compartment since this may lead to precipitation of, for example, carbonates during long term storage or at high pH. Accordingly, bicarbonate and calcium/magnesium must be separated until shortly before use.
One option would be to include calcium in the small compartments containing glucose and bicarbonate in the large compartment . Glucose and calcium/magnesium are largely compatible, i.e. they do not precipitate. However, the divalent ions catalyse glucose decomposition to a certain extent . During mixing of the contents of the small compartment with the contents of the large compartment shortly before use, the risk of precipitation of carbonates is low since the pH- value of the entire solution is maintained well below pH = 7.4.
A conventional peritoneal dialysis solution has a calcium ion concentration of 1.75 mM (mmol/1) and a magnesium ion concentration between 0.25-0.50 mM. The buffer may be solely bicarbonate which thereby normally exists at a concentration of 30-40 mM or a combination of bicarbonate and lactate, for example 25 mM bicarbonate and 15 mM lactate.
In the following, only calcium ions will be considered since they are of the greatest clinical significance, although the principles of the invention is, of course, equally applicable to magnesium ions.
If the above solution were, however, to be used in a three compartment container of the type which is described in WO 97/05852, a problem arises if the calcium ions are included in the small compartments in one and the same concentration. When the contents of one of the small compartments are mixed with the contents of the large compartment, a concentration of 1.5% glucose and, for example, 1.75 mM calcium is created, which is regulated by the quantity of glucose and the concentration of calcium in the first small compartment. If the contents of the second small compartment are mixed with the contents of the large compartment, a concentration of 2.5% glucose and 1.75 mM calcium results, which is regulated by the quantity of glucose and the concentration of calcium in the second small compartment. If, however, the third glucose concentration of 4% is to be obtained, the contents of both the first and the second small compartments are mixed with the contents of the large compartment, whereby a glucose concentration of 4% is obtained, but the calcium concentration becomes too great, in this case about 3.5 mM. It therefore does not seem to be possible to provide a three compartment container of this type offering the possibility of three different glucose concentrations, since the calcium concentration will be too high in the presence of the highest glucose concentration. It would be neccesary to expand the concept to a four compartment container, which, however, might result in new problems of safety. A further object of the present invention is to propose a three compartment container of the above-mentioned type in which the above-mentioned problem is solved.
The problematic issues with calcium for peritoneal dialysis, as well as for haemodialysis, are complicated since dialysis patients normally eat calcium carbonate to bind phosphate which is present in food. A portion of the calcium carbonate which is consumed together with food is absorbed in the intestinal tract and increases the calcium concentration in the blood. At the same time, the calcium carbonate binds phosphate so that the phosphate load on the patient is reduced. Phosphate is a molecule which is difficult to remove from the body via dialysis since it does not pass easily through membranes, whether they be synthetic membranes or peritoneal membranes . The calcium concentration in the peritoneal dialysis solution which is generally recommended today is 1.75 mM. This would seem to be a suitable compromise which corresponds to the normal physiological concentration of free calcium in blood, since calcium is present in blood both freely as well as bound to protein, particularly albumin. If the calcium concentration in the patient is increased, a removal of calcium takes place, whereas if the concentration is too low, calcium is supplied to the body. Should a surplus of calcium arise, hypercalciemia, the following symptoms, among others, result: vomiting, dizziness, reduced muscle function, ECG-disorders and necrosis calcification. Hypercalciemia is usually rectified by the patient avoiding consumption of calcium carbonate for several days, whereupon the calcium concentration quickly reduces.
On the other hand, hypocalciemia results in i.a. the following symptoms: cramps, hyper-reflexes, spasms, ECG- changes and hyperparatyroidism.
Hypocalciemia is normally counteracted by increased intake of calcium carbonate, while the calcium concentration in the dialysis solution is normally kept constant .
It is recognized that the problematics with calcium are difficult since the above-mentioned symptoms are difficult to diagnose .
More recently, it has been proposed to further reduce the calcium concentration in dialysis solution to 1.35, 1.25 or even 1.0 mM. The reason is that the oral intake of calcium carbonate can thereby be increased and further reduce the phosphate charge on the patient. The risk for hypocalciemia increases therewith and increased awareness for diagnosis and treatment is necessary.
Earlier trials have shown that the transport of calcium ions across the peritoneal membrane is affected by the glucose concentration in the peritoneal dialysis solution. This effect is, however, rarely discussed.
According to the present invention, however, this discovery is used to solve the above-mentioned problem in a three compartment container of the type which is described in
WO 97/05852 to thereby adapt this container to a buffer comprising bicarbonate.
Our experiments with simulations of calcium transport across the peritoneal membrane indicate the following unexpected results. If a peritoneal dialysis solution is to be neutral (in- and outflow the same) with regard to the calcium transport during a four hour period, it should comprise about 1.2 mM calcium at 1.5% glucose, about 1.6 mM at 2.5% glucose and, finally, about 2.3 mM calcium at 4.0% glucose, i.e. the calcium concentration should be substantially proportional to the glucose concentration in the final solution.
This can be achieved in a three compartment container by means of calcium being present in substantially the same concentration in the two small glucose compartments. The final glucose concentration in the mixed solution is determined by the volume of the small compartments since the glucose concentration is identical in the small glucose compartments, for example 50%. This results in that the calcium concentration will always remain proportional to the glucose concentration. The higher the glucose concentration (greater volume) , the more ultrafiltration and thus also higher calcium concentration in the mixed solution. The calcium concentration may in that respect be selected so that the patient either has a net loss, net gain or neutral calcium balance irrespective of the ultra- filtration and the glucose concentration.
A further object in the present invention is to provide a three compartment container of the above-mentioned type with bicarbonate in the large compartment and glucose together with calcium in the two small compartments, whereby the increase in the calcium concentration at the highest glucose concentration results in better calcium control than previously. This invention is completely different from previously known methods in which the same calcium concentration has always been used irrespective of the glucose concentration.
By using a peritoneal dialysis solution in which the calcium concentration is proportional to the glucose concentration, it is possible to use one and the same solution in the small compartments, i.e. the equipment which is used to fill the three compartment container need only produce solutions having two different compositions, one for the large compartment and one for the two small compartments. In this manner, the manufacturing costs are reduced. Thus, there is provided according to the invention a container containing a medical solution, particularly for peritoneal dialysis, consisting of a large compartment having a volume which is sufficiently large to contain the finally prepared medical solution, and at least two small compartments which contain partial quantities of the medical solution which are incompatible for long term storage with the contents of the large compartment . The large compartment comprises bicarbonate ions and the small compartments comprises glucose and calcium ions .
According to the invention, it is an advantage if the glucose concentration is substantially proportional to the calcium ion concentration in the finally prepared medical solution.
To obtain such proportional concentration, the two small compartments may comprises solutions having the same concentration of glucose and calcium, though having different volumes, or the first of the small compartments contains glucose and calcium ions with such a concentration that the glucose concentration when mixing the contents of said first small compartment with the contents of the large comparment obtains a first predetermined value, such as 1.5%, and the calcium ion concentration obtains a second predetermined value, such as 1.0 mM, while the second of the small compartments contains glucose and calcium ions having such a concentration so that the glucose concentration in the finally prepared solution when mixing the contents of said second small compartment with the contents of the large comparment obtains a third predetermined value, such as 2.5%, and the calcium ion concentration obtains a fourth predetermined value, such as 1.6 mM, and finally the contents of the first and the second of the small compartments may be mixed with the contents of the large compartment to obtain a finally prepared solution with higher concentrations of glucose and calcium ions, such as 4% glucose concentration and 2.5 mM calcium.
The small compartments may further comprise magnesium ions, for example in a concentration such that the resulting concentration in the finally prepared medical solution is about 0.25-0.75 mM.
The invention also relates to a method for preparing a medical solution, particularly for peritoneal dialysis, in a container consisting of a first large compartment having a volume which is sufficiently large to contain the finally prepared medical solution, and a plurality of small compartments which contain partial quantities of the medical solution which are not compatible for long term storage with the contents of the large compartment. The large compartment comprises bicarbonate ions and the small compartments comprise glucose and calcium ions. The contents of one or more of the small compartments are mixed with the contents of the large compartment to produce a medical solution in which the concentration of glucose is substantially proportional to the concentration of calcium ions.
Finally, the invention also relates to a use of a container for preparation of a peritoneal dialysis solution in which the concentrations of glucose and calcium ions are substantially proportional.
BRIEF DESCRIPTION OF THE DRAWINGS
Further objects, problems, solutions and features will be apparent from the following detailed description of the invention with reference to the drawings describing several embodiments of the invention.
Fig. 1 is a plan view of a container which may be used in the present invention.
Figs. 2, 3 and 4 are computer-simulated diagrams which show the calcium balance across the peritoneal membrane.
DETAILED DESCRIPTION OF PREFERRED EMBODIMENTS
Fig. 1 discloses a three compartment container which may be used in the present invention. The container 1 is of the type which is sealed at both ends with weld seams 20 and 21. The container is divided into a large compartment 10 and two small compartments 14 and 15 by weld seams 11, 12 and 13.
The small compartment 14 and/or 15 may communicate with the large compartment 10 by means of frangible pins 18, 19 which are normally sealed but can be manually opened. When the frangible pin 18 and/or 19 is opened, the contents in the compartments 14 and/or 15 flow down into the large compartment
10 and mix with the contents therein. During manufacture of the container, suitable solution is supplied to the various compartments 10, 14 and 15 via inlet tubes 16, 17 and 22 extending through the weld seams 20 and 21. A sample and/or infusion port 23 extending through the weld seam 21 permits sampling from, and infusion to, the compartment 10.
The solution in the compartment 10 is supplied to a patient via a conduit 24. The container is placed on a stand by means of an opening 25 in the upper weld seam 20. The bag described so far is substantially identical to the one disclosed in WO 97/05852.
The container preferably has a size such that two litres of peritoneal dialysis solution are accommodated in the large compartment 10 in a ready-mixed state. Larger or smaller containers are of course feasible according to the invention.
We have studied the transport of calcium ions across the peritoneal membrane as a function of time, during treatment with a peritoneal dialysis solution comprising glucose as well as different concentrations of calcium ions. Figs. 2, 3 and 4 show the results for glucose concentrations of 1.5%, 2.5% and 4%, respectively. It is apparent that the calcium transport is not only dependent on the concentration gradient across the peritoneal membrane, but also ultrafiltration contributes. A normal CAPD-treatment requires that the patient carries a PD- solution for four hours (240 minutes) and then exchanges it for a fresh PD-solution. If such a PD-solution should result in zero transport of calcium across the peritoneal membrane during the 240 minute period, calcium concentrations of 1.2 mM, 1.6 mM and 2.3 mM respectively are required. The calculations presuppose certain properties of i.a. the peritoneal membrane. We have concluded that a calcium concentration which is substantially proportional to the glucose concentration results in a substantially calcium- neutral treatment, i.e. the calcium transport across the peritoneal membrane will be substantially the same, independent of the selected glucose concentration.
In accordance with the present invention, the container 1 is to be used to prepare a peritoneal dialysis solution in which the buffer consists of bicarbonate. Accordingly, the solutions in the various compartments may be the following.
EXAMPLE 1 The compartment 10 contains 1900 ml with the composition:
sodium bicarbonate 40 mM sodium chloride 132 mM
Compartment 14 contains 100 ml of the composition:
glucose 30% calcium chloride 20 mM magnesium chloride 5 mM sodium chloride 132 mM
Compartment 15 contains 100 ml of the composition:
glucose 50% calcium chloride 33 mM magnesium chloride 8 mM sodium chloride 132 mM
By mixing the contents of compartment 14 and compartment 10, a peritoneal dialysis solution is obtained with the following composition:
glucose 1.5% calcium 1.0 mM bicarbonate 38 mM sodium 132 mM magnesium 0.25 mM
Mixing the contents of compartment 15 and compartment 10 results in a dialysis solution having the composition: glucose 2.5% calcium 1.65 mM bicarbonate 38 mM sodium 132 mM magnesium 0.4 mM
By mixing the contents of both compartments 14 and 15 with the contents of compartment 10, a dialysis solution is obtained having the following composition:
glucose 4.0% calcium 2.5 mM bicarbonate 36 mM sodium 132 mM magnesium 0.6 mM
In a second example of the invention, the contents of each of the small compartments have the same composition according to the following:
EXAMPLE 2
Compartment 10 contains 1950 ml of the composition:
sodium bicarbonate 25 mM sodium lactate 15 mM sodium chloride 132 mM
Compartment 14 contains 60 ml of the composition:
glucose 50% calcium chloride 33 mM magnesium chloride 8 mM sodium chloride 132 mM Compartment 15 contains 100 ml of the composition:
glucose 50% calcium chloride 33 mM magnesium chloride 8 mM sodium chloride 132 mM
In a further alternative embodiment of the present invention, solutions are employed with the following compositions in the various compartments 10, 14 and 15.
EXAMPLE 3
Compartment 10 contains 1850 ml of the composition:
sodium bicarbonate 27 mM sodium lactate 16 mM sodium chloride 132 mM
Compartment 14 contains 150 ml of the composition:
glucose 20% calcium chloride 13 mM magnesium chloride 3.2 mM sodium chloride 132 mM
Compartment 15 contains 260 ml of the composition:
glucose 20% calcium chloride 12.5 mM magnesium chloride 3.1 mM sodium chloride 132 mM
Because of the effect of dilution, the calcium concentration will be somewhat lower than in the first two examples .
To avoid problems with high pH-values, the pH-value in the large compartment is normally adjusted to a pH = 7.2. The pH- value in the small compartments is normally low, about 3.0, in order to prevent glucose decomposition during autoclaving.
When a patient uses a container according to the present invention, he will experience a calcium inflow or outflow which is determined by the concentration of free calcium in the blood and the concentration of calcium in the finally prepared dialysis solution as well as the glucose concentration. In the case with the highest glucose concentration, the net effect will be approximately the same as with the two lower concentrations and the use of the container according to the invention is, therefore, easy and simple for the patient.
The invention has been described above with reference to preferred embodiments of the invention. A skilled person will recognize that further combinations are possible. Modifications which are appearant to a skilled person are intended to be incorporated within the scope of the invention. The invention is limited only by the appended claims.

Claims

1. Container containing a medical solution, particularly for peritoneal dialysis, consisting of a large compartment (10) having a volume which is sufficiently large to contain the finally prepared medical solution, and at least two small compartments (14, 15) which contain partial quantities of the medical solution which are incompatible for long term storage with the contents of the large compartment, characterized in that the large compartment (10) comprises bicarbonate ions and the small compartments (14, 15) comprises glucose and calcium ions .
2. Container according to claim 1, characterized in that the glucose concentration is substantially proportional to the calcium ion concentration in the finally prepared medical solution.
3. Container according to claim 2, characterized in that the small compartments (14, 15) comprises solutions having the same concentration of glucose and calcium, though having different volumes .
4. Container according to claim 1, characterized in that a first (14) of the small compartments contains glucose and calcium ions with such a concentration that the glucose concentration when mixing the contents of said first small compartment with the contents of the large comparment obtains a first predetermined value, such as 1.5%, and the calcium ion concentration obtains a second predetermined value, such as 1.0 mM, a second (15) of the small compartments contains glucose and calcium ions having such a concentration that the glucose concentration in the finally prepared solution when mixing the contents of said second small compartment with the contents of the large comparment obtains a third predetermined value, such as 2.5%, and the calcium ion concentration obtains a fourth predetermined value, such as 1.6 mM, and the contents of the first (14) and the second (15) of the small compartments may be mixed with the contents of the large compartment (10) to obtain a finally prepared solution with higher concentrations of glucose and calcium ions, such as 4% glucose concentration and 2.5 mM calcium.
5. Container according to any one of the preceding claims, characterized in that the small compartments (14, 15) further comprises magnesium ions, for example in a concentration such that the resulting concentration in the finally prepared medical solution is about 0.25-0.75 mM.
6. Method for preparing a medical solution, particularly for peritoneal dialysis, in a container consisting of a first large compartment having a volume which is sufficiently large to contain the finally prepared medical solution, and a plurality of small compartments which contain partial quantities of the medical solution which are not compatible for long term storage with the contents of the large compartment, characterized in that the large compartment comprises bicarbonate ions and the small compartments comprise glucose and calcium ions, and in that the contents of one or more of the small compartments are mixed with the contents of the large compartment to produce a medical solution in which the concentration of glucose is substantially proportional to the concentration of calcium ions .
7. Use of a container according to any one of claims 1-5 for preparation of a peritoneal dialysis solution in which the concentrations of glucose and calcium ions are substantially proportional .
PCT/SE1998/002146 1997-11-28 1998-11-27 Multiple compartment container for medical solution WO1999027885A1 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
JP2000522874A JP2001524353A (en) 1997-11-28 1998-11-27 Medical solution container with multiple compartments
BR9815055-3A BR9815055A (en) 1997-11-28 1998-11-27 Container containing a medical solution, use of it, and process of preparing a medical solution
EP98959333A EP1035823A1 (en) 1997-11-28 1998-11-27 Multiple compartment container for medical solution
AU15153/99A AU742793B2 (en) 1997-11-28 1998-11-27 Multiple compartment container for medical solution
KR1020007005381A KR20010032191A (en) 1997-11-28 1998-11-27 Multiple compartment container for medical solution
CA002311903A CA2311903A1 (en) 1997-11-28 1998-11-27 Multiple compartment container for medical solution

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9704386A SE512349C2 (en) 1997-11-28 1997-11-28 Multi-chamber container for medical solution, procedure for preparation of medical solution for peritoneal dialysis and use of such container for preparation of medical solution
SE9704386-3 1997-11-28

Publications (1)

Publication Number Publication Date
WO1999027885A1 true WO1999027885A1 (en) 1999-06-10

Family

ID=20409165

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/SE1998/002146 WO1999027885A1 (en) 1997-11-28 1998-11-27 Multiple compartment container for medical solution

Country Status (9)

Country Link
EP (1) EP1035823A1 (en)
JP (1) JP2001524353A (en)
KR (1) KR20010032191A (en)
CN (1) CN1280481A (en)
AU (1) AU742793B2 (en)
BR (1) BR9815055A (en)
CA (1) CA2311903A1 (en)
SE (1) SE512349C2 (en)
WO (1) WO1999027885A1 (en)

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100381326B1 (en) * 1997-10-27 2003-04-23 가부시키가이샤 오츠까 세이야꾸 고죠 Packaged ophthalmic perfusate and cleaning fluid bag
WO2004052269A1 (en) * 2002-12-10 2004-06-24 Gambro Lundia Ab A method for preparing a medical solution for the manufacture of a medicament for peritoneal dialysis
WO2004052268A1 (en) * 2002-12-10 2004-06-24 Gambro Lundia Ab A method for preparing a medical solution for the manufacture of a medicament for peritoneal dialysis
US6818179B1 (en) 1999-03-30 2004-11-16 Gambro Lundia Ab Method and apparatus for sterilizing a heat sensitive fluid
US6967002B1 (en) 1999-09-16 2005-11-22 Gambro Lundia Ab Method and apparatus for producing a sterile fluid
US7011855B2 (en) 1994-07-01 2006-03-14 Baxter International Inc. Biochemically balanced peritoneal dialysis solutions
WO2012022775A1 (en) * 2010-08-18 2012-02-23 Fresenius Medical Care Deutschland Gmbh Concentrate for medical solutions, production thereof and use thereof in dialysis
EP1038552B2 (en) † 1999-03-22 2013-11-20 Fresenius Medical Care Deutschland GmbH Solution, in particular a hemodialysis or peritoneal dialysis solution, and method for producing same
WO2014197806A2 (en) 2013-06-07 2014-12-11 Allena Pharmaceuticals, Inc. Compositions, methods, and devices for dialysis
US9004761B2 (en) 2006-05-01 2015-04-14 Baxter International Inc. Multiple chamber container with mistake proof administration system
EP2962683A1 (en) 2003-05-28 2016-01-06 Fresenius Medical Care Deutschland GmbH Low sodium solution
DK201500380A1 (en) * 2015-07-05 2017-04-24 Dorte Dyrsborg Intravenous Bag
US20180280239A1 (en) * 2015-09-03 2018-10-04 Futoshi Miyazaki Kit preparation and dose adjustment method
EP1465688B2 (en) † 2002-01-11 2019-12-04 Nikkiso Co., Ltd. Bicarbonate-based solutions for dialysis therapies

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE524531C2 (en) * 2002-12-10 2004-08-24 Gambro Lundia Ab Solution useful in the manufacture of medicament for peritoneal dialysis e.g. continuous ambulatory peritoneal dialysis comprises acetylated or deacetylated amino sugar in specified amount
SE524530C2 (en) * 2002-12-10 2004-08-24 Gambro Lundia Ab Solution useful in the manufacture of medicament for peritoneal dialysis e.g. continuous ambulatory peritoneal dialysis comprises acetylated or deacetylated amino sugar having specified pH
DE102018103937A1 (en) * 2018-02-21 2019-08-22 Fresenius Medical Care Deutschland Gmbh Device containing dialysis solution or dialysis solution concentrate
US20210205172A1 (en) 2018-08-17 2021-07-08 Regimen Kit, Inc. Drug management method for kit formulation requiring dose adjustment

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0295204A1 (en) * 1987-05-29 1988-12-14 Vifor Medical AG Multiple chamber container for separate storage and subsequent mixture
EP0442406A1 (en) * 1990-02-14 1991-08-21 Material Engineering Technology Laboratory, Inc. Filled and sealed, self-contained mixing container

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0295204A1 (en) * 1987-05-29 1988-12-14 Vifor Medical AG Multiple chamber container for separate storage and subsequent mixture
EP0442406A1 (en) * 1990-02-14 1991-08-21 Material Engineering Technology Laboratory, Inc. Filled and sealed, self-contained mixing container

Cited By (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7011855B2 (en) 1994-07-01 2006-03-14 Baxter International Inc. Biochemically balanced peritoneal dialysis solutions
KR100381326B1 (en) * 1997-10-27 2003-04-23 가부시키가이샤 오츠까 세이야꾸 고죠 Packaged ophthalmic perfusate and cleaning fluid bag
EP1038552B2 (en) † 1999-03-22 2013-11-20 Fresenius Medical Care Deutschland GmbH Solution, in particular a hemodialysis or peritoneal dialysis solution, and method for producing same
US6818179B1 (en) 1999-03-30 2004-11-16 Gambro Lundia Ab Method and apparatus for sterilizing a heat sensitive fluid
US6967002B1 (en) 1999-09-16 2005-11-22 Gambro Lundia Ab Method and apparatus for producing a sterile fluid
EP2322237B1 (en) * 2002-01-11 2020-10-21 Nikkiso Co., Ltd. Bicarbonate-based solutions for dialysis therapies
EP1465688B2 (en) † 2002-01-11 2019-12-04 Nikkiso Co., Ltd. Bicarbonate-based solutions for dialysis therapies
WO2004052268A1 (en) * 2002-12-10 2004-06-24 Gambro Lundia Ab A method for preparing a medical solution for the manufacture of a medicament for peritoneal dialysis
US7790102B2 (en) 2002-12-10 2010-09-07 Gambro Lundia Ab Method for preparing a medical solution for the manufacture of a medicament for peritoneal dialysis
US9918999B2 (en) 2002-12-10 2018-03-20 Fresenius Medical Care Deutschland Gmbh Method for preparing a medical solution for the manufacture of a medicament for peritoneal dialysis
WO2004052269A1 (en) * 2002-12-10 2004-06-24 Gambro Lundia Ab A method for preparing a medical solution for the manufacture of a medicament for peritoneal dialysis
AU2003302889B2 (en) * 2002-12-10 2008-09-11 Gambro Lundia Ab A method for preparing a medical solution for the manufacture of a medicament for peritoneal dialysis
AU2003283940B2 (en) * 2002-12-10 2008-09-11 Gambro Lundia Ab A method for preparing a medical solution for the manufacture of a medicament for peritoneal dialysis
EP2962683A1 (en) 2003-05-28 2016-01-06 Fresenius Medical Care Deutschland GmbH Low sodium solution
US9004761B2 (en) 2006-05-01 2015-04-14 Baxter International Inc. Multiple chamber container with mistake proof administration system
WO2012022775A1 (en) * 2010-08-18 2012-02-23 Fresenius Medical Care Deutschland Gmbh Concentrate for medical solutions, production thereof and use thereof in dialysis
CN103068397A (en) * 2010-08-18 2013-04-24 弗雷森纽斯医疗护理德国有限责任公司 Concentrate for medical solutions, production thereof and use thereof in dialysis
AU2011290707B2 (en) * 2010-08-18 2015-11-12 Fresenius Medical Care Deutschland Gmbh Concentrate for medical solutions, production thereof and use thereof in dialysis
US9249345B2 (en) 2010-08-18 2016-02-02 Fresenius Medical Care Deutschland Gmbh Concentrate for medical solutions, production thereof and use thereof in dialysis
WO2014197806A2 (en) 2013-06-07 2014-12-11 Allena Pharmaceuticals, Inc. Compositions, methods, and devices for dialysis
DK178893B1 (en) * 2015-07-05 2017-05-01 Dorte Dyrsborg Intravenous Bag
DK201500380A1 (en) * 2015-07-05 2017-04-24 Dorte Dyrsborg Intravenous Bag
US20180280239A1 (en) * 2015-09-03 2018-10-04 Futoshi Miyazaki Kit preparation and dose adjustment method
US11554080B2 (en) 2015-09-03 2023-01-17 Futoshi Miyazaki Kit preparation and dose adjustment method

Also Published As

Publication number Publication date
AU742793B2 (en) 2002-01-10
SE9704386D0 (en) 1997-11-28
CN1280481A (en) 2001-01-17
SE9704386L (en) 1999-05-29
EP1035823A1 (en) 2000-09-20
CA2311903A1 (en) 1999-06-10
AU1515399A (en) 1999-06-16
KR20010032191A (en) 2001-04-16
BR9815055A (en) 2002-04-30
SE512349C2 (en) 2000-03-06
JP2001524353A (en) 2001-12-04

Similar Documents

Publication Publication Date Title
AU742793B2 (en) Multiple compartment container for medical solution
AU779950B2 (en) Bicarbonate-based solution in two parts for peritoneal dialysis or substitution in continuous renal replacement therapy
JP5690040B2 (en) Bicarbonate-based peritoneal dialysis solution
TWI326597B (en) Bicarbonate-based solutions for dialysis therapies
AU743889B2 (en) Safety arrangement for a dialysis machine and method of activating the safety arrangement
US9265874B2 (en) Production of individual concentrate
WO1998010745A1 (en) Batch quantity dialysate chemical formulations
JP2001187111A (en) Multichamber container
CN109758632A (en) Multi-vessel system and application thereof
US20080149515A1 (en) Container containing at least two solids and use thereof
JP4135849B2 (en) Solution, in particular a solution for hemodialysis or peritoneal dialysis and method for its preparation
AU2005244434A1 (en) Peritoneal dialysis solution
CN105640930A (en) Iron metabolism-improving agent
JPH08131542A (en) Peritoneum dialysing liquid conditioning solution set
WO2003103688A1 (en) A stable bicarbonate-based solution in a single container
JP2000245826A (en) Neutral peritoneal dialysate
US20160213831A1 (en) Connector with a container for preparing an individually adjusted solution for dialysis
AU7692698A (en) Atrial natriuretic peptide (anp) as an additive to peritoneal dialysis solutions
MXPA00005012A (en) Multiple compartment container for medical solution
Havard Symposium: Salt and Water [Abridged] Thiazide-Induced Antidiuresis in Diabetes Insipidus
Chebrolu et al. Phosphorus-enriched hemodialysis for the treatment of patients with severe methanol intoxication
JP2003088582A (en) Peritoneal dialysate and storage vessel
Feriani et al. Continuous ambulatory peritoneal dialysis with bicarbonate buffer-a pilot study
Der Mesropian et al. Treatment of severe hyponatremia with continuous renal replacement therapy: A case and review of corrective strategies
Mayer Diet and renal disease

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 98811625.1

Country of ref document: CN

AK Designated states

Kind code of ref document: A1

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM HR HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 09554377

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 1998959333

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 1020007005381

Country of ref document: KR

WWE Wipo information: entry into national phase

Ref document number: PA/a/2000/005012

Country of ref document: MX

ENP Entry into the national phase

Ref document number: 2311903

Country of ref document: CA

Ref document number: 2311903

Country of ref document: CA

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 15153/99

Country of ref document: AU

WWP Wipo information: published in national office

Ref document number: 1998959333

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWP Wipo information: published in national office

Ref document number: 1020007005381

Country of ref document: KR

WWG Wipo information: grant in national office

Ref document number: 15153/99

Country of ref document: AU

WWW Wipo information: withdrawn in national office

Ref document number: 1998959333

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1020007005381

Country of ref document: KR